Tag: melanoma

August 26, 2018

5 Top Weekly NASDAQ Biotech Stocks: Bellerophon Leads the Pack

Bellerophon Therapeutics, Chiasma, BioLife Solutions, Cerecor and MiMedx Group were last week's top gainers on the NASDAQ Biotechnology Index.
August 12, 2018

5 Top Weekly NASDAQ Biotech Stocks: Vericel Takes Top Spot

Vericel, AcelRx, Tetraphase Pharmaceuticals, KalVista and Infinity Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
July 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: resTORbio Leads the Pack

resTORbio, ADMA Biologics, Misonix, Novus Therapeutics and Innovate Biopharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 10, 2018

3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma

3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of...
April 30, 2018

8 Glioblastoma Treatment Stocks

With an average survival rate of 16 months, glioblastoma is the most common and deadly type of brain cancer, accounting...
April 30, 2018

Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma

The U.S. Food and Drug Administration (FDA) has accepted priority review the Biologics License Application (BLA) for cemiplimab for the...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.